Journal
BIOMEDICINES
Volume 10, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines10081963
Keywords
chemokine CC motif ligand 4; diabetes mellitus; endothelial progenitor cells; human dermal microvascular endothelial cells; inflammation; wound healing
Categories
Funding
- Ministry of Science and Technology, Executive Yuan, Taiwan [MOST104-2314-B-010-056-MY3]
- Taipei Veterans General Hospital, Taipei, Taiwan [V109C052, V110C-065, VGHUST110-G1-4-1, VGHUST110-G1-4-2]
Ask authors/readers for more resources
This study found that the increased level of CCL4 in diabetes patients is associated with non-healing wounds. Inhibiting CCL4 can restore cell function and accelerate wound healing in diabetic patients. These findings provide a new therapeutic option for clinical treatment of diabetic wounds.
Chronic inflammation in diabetes mellitus (DM) is the leading cause of non-healing wounds. Chemokine CC motif ligand 4 (CCL4) is enhanced in the circulation and in the wounds of DM patients. This study aimed to investigate the effect of endogenous CCL4 inhibition on diabetic wound healing. Endothelial progenitor cells (EPCs) and human dermal microvascular endothelial cells (HDMECs) were used. Mice were injected with streptozotocin to generate hyperglycemia. An enhanced CCL4 level as well as decreased tube formation and migration abilities were observed in high-glucose-treated HDMECs and in EPCs from type 2 DM patients. CCL4 inhibition by siRNA restored the damaged cell function by upregulating the Akt/endothelial nitric oxide synthase/vascular endothelial growth factor/stromal cell-derived factor-1 alpha pathways. Wild-type diabetic mice had delayed wound repair, whereas the CCL4-knockout diabetic mice showed an accelerated rate of wound closure. In a Matrigel plug assay, CCL4-knockout diabetic mice showed higher blood vessel and hemoglobin levels. Higher CD31 and Ki67 expression in the wound area and Matrigel plugs was detected in the CCL4-knockout diabetic mice. CCL4-knockout mice had upregulated angiogenic factors and downregulated inflammatory factors. This study might provide the theoretical basis for CCL4 inhibition as a therapeutic option for clinical diabetic wound treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available